Literature DB >> 23623684

Inhibition of AMPK catabolic action by GSK3.

Tsukasa Suzuki1, Dave Bridges, Daisuke Nakada, Georgios Skiniotis, Sean J Morrison, Jiandie D Lin, Alan R Saltiel, Ken Inoki.   

Abstract

AMP-activated protein kinase (AMPK) regulates cellular energy homeostasis by inhibiting anabolic and activating catabolic processes. While AMPK activation has been extensively studied, mechanisms that inhibit AMPK remain elusive. Here we report that glycogen synthase kinase 3 (GSK3) inhibits AMPK function. GSK3 forms a stable complex with AMPK through interactions with the AMPK β regulatory subunit and phosphorylates the AMPK α catalytic subunit. This phosphorylation enhances the accessibility of the activation loop of the α subunit to phosphatases, thereby inhibiting AMPK kinase activity. Surprisingly, PI3K-Akt signaling, which is a major anabolic signaling and normally inhibits GSK3 activity, promotes GSK3 phosphorylation and inhibition of AMPK, thus revealing how AMPK senses anabolic environments in addition to cellular energy levels. Consistently, disrupting GSK3 function within the AMPK complex sustains higher AMPK activity and cellular catabolic processes even under anabolic conditions, indicating that GSK3 acts as a critical sensor for anabolic signaling to regulate AMPK.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623684      PMCID: PMC3654099          DOI: 10.1016/j.molcel.2013.03.022

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.

Authors:  S Frame; P Cohen; R M Biondi
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

Review 2.  The renaissance of GSK3.

Authors:  P Cohen; S Frame
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

3.  Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.

Authors:  Chunming Liu; Yiming Li; Mikhail Semenov; Chun Han; Gyeong Hun Baeg; Yi Tan; Zhuohua Zhang; Xinhua Lin; Xi He
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

4.  5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase.

Authors:  P A Lochhead; I P Salt; K S Walker; D G Hardie; C Sutherland
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

5.  Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

Authors:  David B Ring; Kirk W Johnson; Erik J Henriksen; John M Nuss; Dane Goff; Tyson R Kinnick; Sylvia T Ma; John W Reeder; Isa Samuels; Trina Slabiak; Allan S Wagman; Mary-Ellen Wernette Hammond; Stephen D Harrison
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

6.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

7.  Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart.

Authors:  Suzanne Kovacic; Carrie-Lynn M Soltys; Amy J Barr; Ichiro Shiojima; Kenneth Walsh; Jason R B Dyck
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

8.  LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.

Authors:  Angela Woods; Stephen R Johnstone; Kristina Dickerson; Fiona C Leiper; Lee G D Fryer; Dietbert Neumann; Uwe Schlattner; Theo Wallimann; Marian Carlson; David Carling
Journal:  Curr Biol       Date:  2003-11-11       Impact factor: 10.834

9.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

Authors:  Brendan D Manning; Andrew R Tee; M Nicole Logsdon; John Blenis; Lewis C Cantley
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

Review 10.  AMP-activated protein kinase: a target for drugs both ancient and modern.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Chem Biol       Date:  2012-10-26
View more
  82 in total

Review 1.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

2.  Cells Deploy a Two-Pronged Strategy to Rectify Misfolded Proinsulin Aggregates.

Authors:  Corey N Cunningham; Jeffrey M Williams; Jeffrey Knupp; Anoop Arunagiri; Peter Arvan; Billy Tsai
Journal:  Mol Cell       Date:  2019-06-05       Impact factor: 17.970

Review 3.  An expanding GSK3 network: implications for aging research.

Authors:  Dylan C Souder; Rozalyn M Anderson
Journal:  Geroscience       Date:  2019-07-17       Impact factor: 7.713

4.  The AMPKα1 Pathway Positively Regulates the Developmental Transition from Proliferation to Quiescence in Trypanosoma brucei.

Authors:  Manuel Saldivia; Gloria Ceballos-Pérez; Jean-Mathieu Bart; Miguel Navarro
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

5.  Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth.

Authors:  Daniela De Zio; Francesca Molinari; Salvatore Rizza; Lucia Gatta; Maria Teresa Ciotti; Anna Maria Salvatore; Søs Grønbæk Mathiassen; Andrzej W Cwetsch; Giuseppe Filomeni; Giuseppe Rosano; Elisabetta Ferraro
Journal:  Cell Mol Life Sci       Date:  2015-05-15       Impact factor: 9.261

6.  mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3β.

Authors:  Stephen J Bautista; Ivan Boras; Adriano Vissa; Noa Mecica; Christopher M Yip; Peter K Kim; Costin N Antonescu
Journal:  J Biol Chem       Date:  2018-07-30       Impact factor: 5.157

7.  TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue.

Authors:  Peng Zhao; Kai In Wong; Xiaoli Sun; Shannon M Reilly; Maeran Uhm; Zhongji Liao; Yuliya Skorobogatko; Alan R Saltiel
Journal:  Cell       Date:  2018-02-08       Impact factor: 41.582

8.  Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer.

Authors:  Krishnendu Pal; Ying Cao; Irina N Gaisina; Santanu Bhattacharya; Shamit K Dutta; Enfeng Wang; Hendra Gunosewoyo; Alan P Kozikowski; Daniel D Billadeau; Debabrata Mukhopadhyay
Journal:  Mol Cancer Ther       Date:  2013-12-10       Impact factor: 6.261

9.  Histone deacetylase HDA6 enhances brassinosteroid signaling by inhibiting the BIN2 kinase.

Authors:  Yuhan Hao; Haijiao Wang; Shenglong Qiao; Linna Leng; Xuelu Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

10.  AMP-Activated Protein Kinase and Glycogen Synthase Kinase 3β Modulate the Severity of Sepsis-Induced Lung Injury.

Authors:  Zhongyu Liu; Nathaniel Bone; Shaoning Jiang; Dae Won Park; Jean-Marc Tadie; Jessy Deshane; Cilina Ann Rodriguez; Jean-Francois Pittet; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2015-11-30       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.